16.07.2025 • News

Covestro Extends Contract with CTO Thorsten Dreier Until 2031

Thorsten Dreier will remain Covestro's Chief Technology Officer for another five years. The Supervisory Board has extended his contract until June 30, 2031.

Thorsten Dreier
Thorsten Dreier, Chief Technology Officer, Covestro
© Covestro

Dreier has been Chief Technology Officer and a member of the Covestro Board of Management since July 2023 and Labor Director since September 2023.

"Thorsten Dreier has significantly advanced Covestro's transition to climate-neutral production over the past two years, making an important contribution to Covestro's vision of a circular economy,” said Richard Pott, Chair of the Supervisory Board of Covestro AG. “We are convinced that Mr. Dreier will successfully continue the transformation of Covestro and we look forward to our continued collaboration."

"I am grateful for the trust placed in me. I am looking very much forward to continuing to drive the transformation of our company together with the Covestro employees and the Board of Management," said Dreier. “As Labor Director, it is very important to me to continue the trusting and constructive collaboration with the employees and the employee representatives that I have been able to establish in the past years."

In his role as Chief Technology Officer, Dreier is responsible for the corporate functions of Engineering, Process Technology, Group Health, Safety, Environment & Reliability, and Group Procurement. He is also responsible for the Performance Materials reporting segment.

Other members of Covestro's five-member Board of Management are CEO Markus Steilemann, Christian Baier as Chief Financial Officer, Sucheta Govil as Chief Sales and Marketing Officer, and Monique Buch, who will succeed Sucheta Govil as Chief Sales and Marketing Officer from August 2025.

Company

Logo:

Covestro


51368 Leverkusen
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read